0002067583-26-000002.txt : 20261020 0002067583-26-000002.hdr.sgml : 20261020 20261020144114 ACCESSION NUMBER: 0002067583-26-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20261020 DATE AS OF CHANGE: 20261020 EFFECTIVENESS DATE: 20261020 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Crosslink Therapeutics Inc. CENTRAL INDEX KEY: 0002067583 ORGANIZATION NAME: EIN: 881007678 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-601863 FILM NUMBER: 261472215 BUSINESS ADDRESS: STREET 1: 349-351 NEWBURY STREET CITY: BOSTON STATE: MA ZIP: 02115 BUSINESS PHONE: 404-861-1253 MAIL ADDRESS: STREET 1: 349-351 NEWBURY STREET CITY: BOSTON STATE: MA ZIP: 02115 D 1 primary_doc.xml X0708 D LIVE 0002067583 Crosslink Therapeutics Inc. 349-351 NEWBURY STREET BOSTON MA MASSACHUSETTS 02115 404-861-1253 DELAWARE None None Corporation true 2021 Ronald D. Seidel, III 349-351 Newbury Street Boston MA MASSACHUSETTS 02115 Executive Officer Director Andrew King 349-351 Newbury Street Boston MA MASSACHUSETTS 02115 Director Lou Tartaglia 349-351 Newbury Street Boston MA MASSACHUSETTS 02115 Director Rodolfo Chaparro 349-351 Newbury Street Boston MA MASSACHUSETTS 02115 Director David Fallace 349-351 Newbury Street Boston MA MASSACHUSETTS 02115 Director Cameron Gallagher 349-351 Newbury Street Boston MA MASSACHUSETTS 02115 Director Pharmaceuticals Decline to Disclose 06b false 2026-10-08 false true true false 0 5500000 5500000 0 false 8 0 0 0 false Crosslink Therapeutics Inc. Ronald D. Seidel, III Ronald D. Seidel, III Chief Executive Officer 2026-10-20